These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 17653129)
1. Noninvasive estimation of normalized distribution volume: application to the muscarinic-2 ligand [(18)F]FP-TZTP. Ichise M; Cohen RM; Carson RE J Cereb Blood Flow Metab; 2008 Feb; 28(2):420-30. PubMed ID: 17653129 [TBL] [Abstract][Full Text] [Related]
2. Age and APOE-epsilon4 genotype influence the effect of physostigmine infusion on the in-vivo distribution volume of the muscarinic-2-receptor dependent tracer [18F]FP-TZTP. Cohen RM; Carson RE; Filbey F; Szczepanik J; Sunderland T Synapse; 2006 Jul; 60(1):86-92. PubMed ID: 16598702 [TBL] [Abstract][Full Text] [Related]
3. Higher in vivo muscarinic-2 receptor distribution volumes in aging subjects with an apolipoprotein E-epsilon4 allele. Cohen RM; Podruchny TA; Bokde AL; Carson RE; Herscovitch P; Kiesewetter DO; Eckelman WC; Sunderland T Synapse; 2003 Sep; 49(3):150-6. PubMed ID: 12774299 [TBL] [Abstract][Full Text] [Related]
4. In vivo muscarinic 2 receptor imaging in cognitively normal young and older volunteers. Podruchny TA; Connolly C; Bokde A; Herscovitch P; Eckelman WC; Kiesewetter DO; Sunderland T; Carson RE; Cohen RM Synapse; 2003 Apr; 48(1):39-44. PubMed ID: 12557271 [TBL] [Abstract][Full Text] [Related]
5. Why does the agonist [(18)F]FP-TZTP bind preferentially to the M(2) muscarinic receptor? Ravasi L; Kiesewetter DO; Shimoji K; Lucignani G; Eckelman WC Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):292-300. PubMed ID: 16333673 [TBL] [Abstract][Full Text] [Related]
6. Muscarinic cholinergic receptor measurements with [18F]FP-TZTP: control and competition studies. Carson RE; Kiesewetter DO; Jagoda E; Der MG; Herscovitch P; Eckelman WC J Cereb Blood Flow Metab; 1998 Oct; 18(10):1130-42. PubMed ID: 9778190 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of [18F]FP-TZTP binding by loading doses of muscarinic agonists P-TZTP or FP-TZTP in vivo is not due to agonist-induced reduction in cerebral blood flow. Shimoji K; Esaki T; Itoh Y; Ravasi L; Cook M; Jehle J; Jagoda EM; Kiesewetter DO; Schmidt K; Sokoloff L; Eckelman WC Synapse; 2003 Nov; 50(2):151-63. PubMed ID: 12923818 [TBL] [Abstract][Full Text] [Related]
8. Imaging of the muscarinic acetylcholine neuroreceptor in rats with the M2 selective agonist [18F]FP-TZTP. Ravasi L; Tokugawa J; Nakayama T; Seidel J; Sokoloff L; Eckelman WC; Kiesewetter DO Nucl Med Biol; 2012 Jan; 39(1):45-55. PubMed ID: 21831648 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the pharmacokinetics of different analogs of 11C-labeled TZTP for imaging muscarinic M2 receptors with PET. Reid AE; Ding YS; Eckelman WC; Logan J; Alexoff D; Shea C; Xu Y; Fowler JS Nucl Med Biol; 2008 Apr; 35(3):287-98. PubMed ID: 18355684 [TBL] [Abstract][Full Text] [Related]
10. Regional brain uptake of the muscarinic ligand, [18F]FP-TZTP, is greatly decreased in M2 receptor knockout mice but not in M1, M3 and M4 receptor knockout mice. Jagoda EM; Kiesewetter DO; Shimoji K; Ravasi L; Yamada M; Gomeza J; Wess J; Eckelman WC Neuropharmacology; 2003 Apr; 44(5):653-61. PubMed ID: 12668051 [TBL] [Abstract][Full Text] [Related]
11. Simplified parametric methods for [18F]FDDNP studies. Yaqub M; Tolboom N; van Berckel BN; Scheltens P; Lammertsma AA; Boellaard R Neuroimage; 2010 Jan; 49(1):433-41. PubMed ID: 19643186 [TBL] [Abstract][Full Text] [Related]
12. Reduced muscarinic type 2 receptor binding in subjects with bipolar disorder. Cannon DM; Carson RE; Nugent AC; Eckelman WC; Kiesewetter DO; Williams J; Rollis D; Drevets M; Gandhi S; Solorio G; Drevets WC Arch Gen Psychiatry; 2006 Jul; 63(7):741-7. PubMed ID: 16818863 [TBL] [Abstract][Full Text] [Related]
13. Genetic variation in cholinergic muscarinic-2 receptor gene modulates M2 receptor binding in vivo and accounts for reduced binding in bipolar disorder. Cannon DM; Klaver JK; Gandhi SK; Solorio G; Peck SA; Erickson K; Akula N; Savitz J; Eckelman WC; Furey ML; Sahakian BJ; McMahon FJ; Drevets WC Mol Psychiatry; 2011 Apr; 16(4):407-18. PubMed ID: 20351719 [TBL] [Abstract][Full Text] [Related]
14. PET imaging of serotonin transporters with [11C]DASB: test-retest reproducibility using a multilinear reference tissue parametric imaging method. Kim JS; Ichise M; Sangare J; Innis RB J Nucl Med; 2006 Feb; 47(2):208-14. PubMed ID: 16455625 [TBL] [Abstract][Full Text] [Related]
15. An improved radiosynthesis of the muscarinic M2 radiopharmaceutical, [18F]FP-TZTP. van Oosten EM; Wilson AA; Stephenson KA; Mamo DC; Pollock BG; Mulsant BH; Yudin AK; Houle S; Vasdev N Appl Radiat Isot; 2009 Apr; 67(4):611-6. PubMed ID: 19186063 [TBL] [Abstract][Full Text] [Related]
16. Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain. Ichise M; Liow JS; Lu JQ; Takano A; Model K; Toyama H; Suhara T; Suzuki K; Innis RB; Carson RE J Cereb Blood Flow Metab; 2003 Sep; 23(9):1096-112. PubMed ID: 12973026 [TBL] [Abstract][Full Text] [Related]
17. Test-retest reproducibility of the metabotropic glutamate receptor 5 ligand [¹⁸F]FPEB with bolus plus constant infusion in humans. Park E; Sullivan JM; Planeta B; Gallezot JD; Lim K; Lin SF; Ropchan J; McCarthy TJ; Ding YS; Morris ED; Williams WA; Huang Y; Carson RE Eur J Nucl Med Mol Imaging; 2015 Sep; 42(10):1530-41. PubMed ID: 26044120 [TBL] [Abstract][Full Text] [Related]
18. Parametric imaging and quantitative analysis of the PET amyloid ligand [(18)F]flutemetamol. Heurling K; Buckley C; Van Laere K; Vandenberghe R; Lubberink M Neuroimage; 2015 Nov; 121():184-92. PubMed ID: 26209803 [TBL] [Abstract][Full Text] [Related]
19. PET imaging evaluation of [(18)F]DBT-10, a novel radioligand specific to α7 nicotinic acetylcholine receptors, in nonhuman primates. Hillmer AT; Zheng MQ; Li S; Scheunemann M; Lin SF; Holden D; Labaree D; Ropchan J; Teodoro R; Deuther-Conrad W; Carson RE; Brust P; Huang Y Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):537-47. PubMed ID: 26455500 [TBL] [Abstract][Full Text] [Related]
20. A potential cholinergic mechanism of procaine's limbic activation. Benson BE; Carson RE; Kiesewetter DO; Herscovitch P; Eckelman WC; Post RM; Ketter TA Neuropsychopharmacology; 2004 Jul; 29(7):1239-50. PubMed ID: 14997171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]